FindTrial
Sign In

Tendyne Mitral Valve System

DEVICE4 trials

Sponsors

Abbott Medical Devices, LMU Klinikum

Conditions

Cardiovascular DiseasesDegenerative Mitral Valve DiseaseFunctional Mitral RegurgitationHeart Valve CalcificationHeart Valve DiseasesMitral Annular CalcificationMitral Annulus CalcificationMitral Insufficiency

Unknown Phase

Expanded Clinical Study of the Tendyne Mitral Valve System
CompletedNCT02321514
Abbott Medical DevicesMitral Valve Regurgitation
Start: 2014-11-30End: 2025-04-30Updated: 2025-07-17
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Active, not recruitingNCT03433274
Abbott Medical DevicesCardiovascular Diseases, Degenerative Mitral Valve Disease, Functional Mitral Regurgitation +5
Start: 2018-06-15End: 2028-06-01Updated: 2026-07-23
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
CompletedNCT03539458
Abbott Medical DevicesCardiovascular Diseases, Heart Valve Calcification, Heart Valve Diseases +6
Start: 2018-10-10End: 2024-06-18Updated: 2024-11-18
Tendyne European Experience Registry
RecruitingNCT04898335
LMU KlinikumMitral Regurgitation
Start: 2021-04-15End: 2027-12-31Target: 400Updated: 2021-05-24

Related Papers

Transapical Mitral Valve Replacement: 1-Year Results of the Real-World Tendyne European Experience Registry.
2024-02-2126 citations
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification.
2022-04-0139 citations
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.
2021-11-0191 citations
Machine learning for estimating individual treatment effects in randomized controlled trials
2021-09-05
Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial.
2016-12-28188 citations